Back

Interpretable biomarker discovery from small-sample microarray datasets using XGBoost rank aggregation and SVM-RFECV

Prapty, M. M.; Rahman, M. S.

2026-08-21 bioinformatics
10.64898/2026.08.13.744652 bioRxiv
Show abstract

MotivationHigh-dimensional microarray datasets remain valuable for cancer biomarker discovery, but their small sample sizes make robust and interpretable feature selection challenging. Efficient workflows are needed to derive compact gene signatures while preserving biological interpretability. ResultsWe developed a two-stage biomarker-discovery workflow that combines cross-validated XGBoost rank aggregation with support vector machine recursive feature elimination and cross-validation (SVM-RFECV) to identify compact candidate biomarker panels. The workflow was evaluated on 21 public binary and multiclass microarray datasets using repeated stratified cross-validation for internal validation. Across the dataset collection, the selected panels demonstrated strong internal discriminative performance while remaining sufficiently compact for downstream biological interpretation. SHAP analysis identified dataset- and class-specific discriminative genes, and functional enrichment analysis supported the biological coherence of representative consensus signatures. The proposed workflow provides an interpretable and reproducible framework for candidate biomarker discovery from small-sample microarray datasets. AvailabilitySource code and processed outputs are freely available at https://github.com/mashiyat-mahjabin-prapty/microarray-feature-selection.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.